Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality ...

MARS is an albumin-dialysis-based device that has been used to treat acute-on-chronic liver failure (ACLF). The treatment is based on the removal from the blood of protein-bound toxins ...

Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological ...

Low albumin (hypoalbuminemia) is most often due to the reduced production of albumin by the liver or the excessive loss of albumin in urine (due to a kidney problem). Chronic inflammatory diseases ...

The Model for End-Stage Liver Disease (MELD) score has played a pivotal role in assessing the severity of liver disease and prioritizing liver ...

The researchers derived a model including PIVKA-II combined with age, sex, alanine transaminase, aspartate aminotransferase, ...